Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Giampaolo Bianchini, MD, IRCCS San Raffaele Hospital, Milan, Italy, discusses single-cell spatial analysis by imaging mass cytometry and immunotherapy response in patients with triple-negative breast cancer (TNBC) who were enrolled in the NeoTRIPaPDL1 trial (NCT02620280). This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.